BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6612600)

  • 1. [Study of corinfar and isoptin pharmacodynamics using impedance cardiography and tetrapolar rheoplethysmography of the finger in patients with ischemic heart disease].
    Shinbaeva NA; Pushkar' IuT; Metelitsa VI
    Ter Arkh; 1983; 55(5):48-53. PubMed ID: 6612600
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of calcium antagonists on the hemodynamic function in patients with heart failure].
    Gorb IuG; Seab KhK; Mikliaev IIu
    Vrach Delo; 1990 Jul; (7):19-21. PubMed ID: 2238587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium channel blocking agents.
    Ewy GA
    Med Times; 1981 Aug; 109(8):36-8. PubMed ID: 6268924
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacodynamic study of nitroglycerin preparations by methods of tetrapolar rheoplethysmography of the finger and impedance cardiography in ischemic heart disease].
    Savvateev KL; Pushkar' IuT
    Kardiologiia; 1980 Dec; 20(12):89-92. PubMed ID: 6782321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Calcium antagonists in stress angina pectoris (pharmacodynamic study)].
    Nikolenko SA; Metelitsa VI; Shinbaeva NA; Savvateev KL
    Kardiologiia; 1982 Nov; 22(11):31-7. PubMed ID: 7154504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemodynamic and coronary changes induced by various slow-channel inhibitors in chronic coronary insufficiency: nifedipine, verapamil and bepridil].
    Merillon JP; Duffloux MA; Eustigneff T; Pansard Y; Guiomard A; Zygelman M; Aumont MC; Gourgon R
    Therapie; 1981; 36(2):123-34. PubMed ID: 6270840
    [No Abstract]   [Full Text] [Related]  

  • 7. [Calcium-antagonist-type cardiac effects of nifedipine in vitro and in vivo. Comparative experimental study].
    Cosín J; Gimeno JV; Martín G; Ramírez A; Ferrer J; Báguena J
    Rev Esp Cardiol; 1982; 35(5 Suppl 2):II115-22. PubMed ID: 7170402
    [No Abstract]   [Full Text] [Related]  

  • 8. [Chemotherapy in ischemic heart disease. Experience with Nifedipine (Corinfar)].
    Schwela H; Oltmanns G; Assmann I; Barthels U; Fiehring H
    Z Gesamte Inn Med; 1977 Oct; 32(19):479-83. PubMed ID: 339576
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiovascular effects of nifedipine--a 4-week treatment in preselected patients with coronary disease.
    Słomińska-Petelenz T; Petelenz T; Chruściel TL; Wilk J; Elertowicz M; Axenti I
    Int J Clin Pharmacol Ther Toxicol; 1982 Mar; 20(3):122-7. PubMed ID: 7068285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of corinfar on hemodynamics in ischemic heart disease].
    Gol'dberg GA; Ermakova EN; Shakhshneĭder NM
    Ter Arkh; 1986; 58(5):87-90. PubMed ID: 3526617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium channel blockers: rationale for their clinical use.
    Conti CR
    J Fla Med Assoc; 1981 Nov; 68(11):883-6. PubMed ID: 6120992
    [No Abstract]   [Full Text] [Related]  

  • 12. [Electrophysiologic effects of nifedipine in humans. Comparison with verapamil].
    Gutiérrez L; Valle V; Cinca J; Ríus J
    Rev Esp Cardiol; 1982; 35(5 Suppl 2):II1-5. PubMed ID: 7170400
    [No Abstract]   [Full Text] [Related]  

  • 13. [Left ventricular hypertrophy as an indication for the prescribing of calcium antagonists in patients with ischemic heart disease].
    Ianovskiĭ GV; Golub' NS; Vysotskaia ZhM; Stadniuk LA; Kovtun LI
    Vrach Delo; 1991 Jul; (7):39-41. PubMed ID: 1837639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood flow in normal and acutely ischemic myocardium after verapamil, diltiazem and nisoldipine (Bay k 5552), a new dihydropyridine calcium antagonist.
    Warltier DC; Meils CM; Gross GJ; Brooks HL
    J Pharmacol Exp Ther; 1981 Jul; 218(1):296-302. PubMed ID: 7248040
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative pharmacodynamics study of korinfar and isoptin in ischemic heart disease].
    Savvateev KL; Shinbaeva NA; Vygodin VA; Nikolenko SA
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1981; 4(1):64-70. PubMed ID: 7259869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative study of the acute hemodynamic effects of verapamil and nifedipine in patients with ischemic heart disease].
    Manfroi WC; Vieira SR; Ludwig RT; Goldim JR; Faraco EZ
    Arq Bras Cardiol; 1987 Feb; 48(2):123-8. PubMed ID: 3675228
    [No Abstract]   [Full Text] [Related]  

  • 17. Protection of infarcting myocardium by slow channel inhibitors. Comparative effects of verapamil, nifedipine, and diltiazem in the coronary-ligated, isolated working rat heart.
    Hamm CW; Opie LH
    Circ Res; 1983 Feb; 52(2 Pt 2):I129-38. PubMed ID: 6831647
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of calcium antagonists (verapamil and nifedipine) on blood levels of calcium and cyclic AMP in humans].
    Nami R; Martinelli M; Lo Monaco B; Pizzuti M; Nardi PL; D'Ascenzo G; Gennari C
    Minerva Cardioangiol; 1981 Jun; 29(6):339-50. PubMed ID: 6269022
    [No Abstract]   [Full Text] [Related]  

  • 19. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
    Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium-channel blocking agents.
    Leonard RG; Talbert RL
    Clin Pharm; 1982; 1(1):17-33. PubMed ID: 6764159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.